Back to mobile site

Goldman Sachs Reiterates Buy Rating on Abbott Labs (ABT)

July 17, 2025 9:45 AM EDT Send to a Friend
Goldman Sachs analyst David Roman reiterated a Buy rating and $153.00 price target on Abbott Labs (NYSE: ABT).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login